Viewing Study NCT02733068


Ignite Creation Date: 2025-12-24 @ 5:39 PM
Ignite Modification Date: 2026-02-22 @ 11:40 PM
Study NCT ID: NCT02733068
Status: COMPLETED
Last Update Posted: 2022-12-19
First Post: 2016-02-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.
Sponsor: Shanghai Zerun Biotechnology Co.,Ltd
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Human Papilloma Virus Infection Type 16 View
None Human Papilloma Virus Infection Type 18 View
None Cervical Intraepithelial Neoplasia View
Keywords: